Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Aug 31, 2025 | (Q2)May 31, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 166.91%375.19K | -16.98%162.18K | 4.57%148.15K | -22.09%629.94K | -53.94%152.34K | 22.32%140.57K | 16.52%195.36K | -27.44%141.68K | -2.29%808.6K | -18.67%330.78K |
| Selling and administrative expenses | 178.23%369.86K | -16.89%126.85K | 3.74%130.24K | -22.29%560.45K | -54.44%149.35K | 18.73%132.93K | 19.86%152.62K | -18.53%125.54K | -1.92%721.18K | -12.39%327.78K |
| -General and administrative expense | 178.23%369.86K | -16.89%126.85K | 3.74%130.24K | -22.29%560.45K | -54.44%149.35K | 18.73%132.93K | 19.86%152.62K | -18.53%125.54K | -1.92%721.18K | -12.39%327.78K |
| Other operating expenses | -30.14%5.33K | -17.32%35.33K | 11.06%17.92K | -20.50%69.49K | 0.07%3K | 158.34%7.63K | 5.98%42.73K | -60.79%16.13K | -5.23%87.41K | -90.81%2.99K |
| Operating profit | -166.91%-375.19K | 16.98%-162.18K | -4.57%-148.15K | 22.09%-629.94K | 53.94%-152.34K | -22.32%-140.57K | -16.52%-195.36K | 27.44%-141.68K | 2.29%-808.6K | 18.67%-330.78K |
| Net non-operating interest income (expenses) | 7.88%4.77K | -48.91%3.42K | -2.89%4.17K | 71.45%18.35K | 98.51%2.94K | 91.50%4.42K | 108.01%6.7K | 16.21%4.29K | 6.31%10.7K | -67.18%1.48K |
| Non-operating interest income | 7.88%4.77K | -48.91%3.42K | -2.89%4.17K | 71.45%18.35K | 98.51%2.94K | 91.50%4.42K | 108.01%6.7K | 16.21%4.29K | 6.31%10.7K | -67.18%1.48K |
| Other net income (expenses) | -421.81%-85.05K | -154.60%-37.65K | 4,373.15%56.02K | 101.86%29.27K | 95.96%-64.79K | -61.62%26.43K | 622.16%68.95K | 94.03%-1.31K | -1,047.76%-1.57M | -333.71%-1.6M |
| Gain on sale of security | -46.43%11.4K | -216.61%-1.09K | 110.85%3.62K | 106.38%7.68K | 341.71%18.8K | -66.57%21.27K | 100.97%933 | 63.76%-33.32K | -572.74%-120.3K | -81.61%4.26K |
| Special income (charges) | --0 | ---77.5K | 46.41%-3.1K | 93.26%-105.78K | 93.63%-100K | --0 | --0 | ---5.78K | -1,327.82%-1.57M | -327.97%-1.57M |
| -Less:Impairment of capital assets | --0 | --0 | -46.41%3.1K | -93.26%105.78K | -93.63%100K | --0 | --0 | --5.78K | 127.25%1.57M | 1,107.20%1.57M |
| -Gain on sale of business | --0 | ---77.5K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | -1,969.76%-96.44K | -39.81%40.94K | 46.86%55.5K | 6.65%127.38K | 142.27%16.41K | -1.28%5.16K | -18.07%68.02K | -46.01%37.79K | 861.08%119.43K | -53.59%-38.81K |
| Income before tax | -315.12%-455.47K | -64.07%-196.4K | 36.58%-87.96K | 75.42%-582.31K | 88.92%-214.2K | -150.76%-109.72K | 32.61%-119.7K | 35.04%-138.69K | -263.45%-2.37M | -780.15%-1.93M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -315.12%-455.47K | -64.07%-196.4K | 36.58%-87.96K | 75.42%-582.31K | 88.92%-214.2K | -150.76%-109.72K | 32.61%-119.7K | 35.04%-138.69K | -263.45%-2.37M | -780.15%-1.93M |
| Net income continuous operations | -315.12%-455.47K | -64.07%-196.4K | 36.58%-87.96K | 75.42%-582.31K | 88.92%-214.2K | -150.76%-109.72K | 32.61%-119.7K | 35.04%-138.69K | -263.45%-2.37M | -780.15%-1.93M |
| Noncontrolling interests | -33.44%-5.6K | 341.87%1.61K | 83.47%-478 | 86.98%-11.54K | 95.55%-3.79K | 0.92%-4.2K | -610.77%-664 | -533.43%-2.89K | -363.67%-88.7K | -1,793.38%-85.26K |
| Net income attributable to the company | -326.32%-449.87K | -66.34%-198.01K | 35.58%-87.48K | 74.97%-570.77K | 88.62%-210.4K | -167.01%-105.53K | 33.04%-119.04K | 36.59%-135.8K | -260.42%-2.28M | -740.02%-1.85M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -326.32%-449.87K | -66.34%-198.01K | 35.58%-87.48K | 74.97%-570.77K | 88.62%-210.4K | -167.01%-105.53K | 33.04%-119.04K | 36.59%-135.8K | -260.42%-2.28M | -740.02%-1.85M |
| Diluted earnings per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -208.83%-0.01 | -624.24%-0.0078 |
| Basic earnings per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -208.83%-0.01 | -624.24%-0.0078 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.